AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionTocqueville Asset Management L.p.
Latest Disclosed Ownership337,526 shares
Latest Disclosed Value $ 73,408,530
Tocqueville Asset Management L.p. reports 1.09% increase in ownership of 4AB / AbbVie Inc.

On May 12, 2026 - Tocqueville Asset Management L.p. filed a 13F-HR form disclosing ownership of 337,526 shares of AbbVie Inc. (BG:4AB) valued at $73,408,530 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 333,901 shares of AbbVie Inc.. This represents a change in shares of 1.09% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F ABBVIE COM 00287Y109 337,526 3,625 1.09 73,409 -3.78 1.0886
2026-02-12 2025-12-31 13F ABBVIE COM 00287Y109 333,901 -1,330 -0.40 76,293 -1.71 1.1129
2025-11-13 2025-09-30 13F ABBVIE COM 00287Y109 335,231 -11,077 -3.20 77,619 20.75 1.1284
2025-08-12 2025-06-30 13F ABBVIE COM 00287Y109 346,308 -49,143 -12.43 64,282 -22.42 0.9786
2025-05-13 2025-03-31 13F ABBVIE COM 00287Y109 395,451 2,839 0.72 82,855 18.76 1.3530
2025-02-10 2024-12-31 13F ABBVIE COM 00287Y109 392,612 82,182 26.47 69,767 13.81 1.0942
2024-11-08 2024-09-30 13F ABBVIE COM 00287Y109 310,430 -5,603 -1.77 61,304 13.09 0.9630
2024-08-12 2024-06-30 13F ABBVIE COM 00287Y109 316,033 49,186 18.43 54,206 11.55 0.8948
2024-05-09 2024-03-31 13F ABBVIE COM 00287Y109 266,847 -2,468 -0.92 48,593 16.43 0.7938
2024-02-12 2023-12-31 13F ABBVIE COM 00287Y109 269,315 -5,775 -2.10 41,736 1.78 0.7565
2023-11-09 2023-09-30 13F ABBVIE COM 00287Y109 275,090 -5,436 -1.94 41,005 8.49 0.7788
2023-08-11 2023-06-30 13F ABBVIE COM 00287Y109 280,526 -2,531 -0.89 37,795 -16.22 0.6768
2023-05-10 2023-03-31 13F ABBVIE COM 00287Y109 283,057 -1,774 -0.62 45,111 -2.00 0.8522
2023-02-09 2022-12-31 13F ABBVIE COM 00287Y109 284,831 5,859 2.10 46,032 22.94 0.8743
2022-11-10 2022-09-30 13F ABBVIE COM 00287Y109 278,972 -2,007 -0.71 37,441 -13.00 0.7632
2022-08-12 2022-06-30 13F ABBVIE COM 00287Y109 280,979 5,864 2.13 43,035 -3.51 0.7870
2022-05-16 2022-03-31 13F Abbvie COM 00287Y109 275,115 -8,053 -2.84 44,599 16.32 0.6738
2022-02-14 2021-12-31 13F ABBVIE COM 00287Y109 283,168 2,080 0.74 38,341 26.45 0.5274
2021-11-15 2021-09-30 13F ABBVIE COM 00287Y109 281,088 940 0.34 30,321 -3.91 0.4492
2021-08-16 2021-06-30 13F ABBVIE COM 00287Y109 280,148 795 0.28 31,556 4.38 0.4559
2021-05-17 2021-03-31 13F ABBVIE COM 00287Y109 279,353 -1,040 -0.37 30,232 0.63 0.4652
2021-02-16 2020-12-31 13F ABBVIE COM 00287Y109 280,393 623 0.22 30,044 22.60 0.5015
2020-11-16 2020-09-30 13F ABBVIE COM 00287Y109 279,770 237 0.08 24,505 -10.71 0.4688
2020-08-12 2020-06-30 13F ABBVIE COM 00287Y109 279,533 12,012 4.49 27,445 34.65 0.5723
2020-05-15 2020-03-31 13F ABBVIE COM 00287Y109 267,521 -19,684 -6.85 20,382 -19.85 0.5064
2020-01-14 2019-12-31 13F Abbvie COM 00287Y109 287,205 -10,225 -3.44 25,429 12.91 0.3740
2019-10-31 2019-09-30 13F Abbvie COM 00287Y109 297,430 6,505 2.24 22,521 6.45 0.3056
2019-07-31 2019-06-30 13F Abbvie COM 00287Y109 290,925 38,561 15.28 21,156 4.02 0.2742
2019-04-30 2019-03-31 13F Abbvie COM 00287Y109 252,364 -11,716 -4.44 20,338 -16.46 0.2715
2019-02-08 2018-12-31 13F Abbvie COM 00287Y109 264,080 -148,157 -35.94 24,346 -37.56 0.3648
2018-11-13 2018-09-30 13F Abbvie COM 00287Y109 412,237 -1,385 -0.33 38,989 1.74 0.4912
2018-08-13 2018-06-30 13F Abbvie COM 00287Y109 413,622 -74,054 -15.19 38,322 -16.98 0.4861
2018-05-14 2018-03-31 13F Abbvie COM 00287Y109 487,676 -44,002 -8.28 46,159 -10.23 0.5881
2018-02-13 2017-12-31 13F Abbvie COM 00287Y109 531,678 -11,467 -2.11 51,419 6.54 0.5838
2017-10-30 2017-09-30 13F Abbvie COM 00287Y109 543,145 -78,315 -12.60 48,264 7.11 0.5551
2017-08-04 2017-06-30 13F Abbvie COM 00287Y109 621,460 -725 -0.12 45,062 11.15 0.5406
2017-04-28 2017-03-31 13F Abbvie COM 00287Y109 622,185 -63,567 -9.27 40,542 -5.59 0.4947
2017-01-30 2016-12-31 13F Abbvie COM 00287Y109 685,752 -262,332 -27.67 42,942 -28.19 0.5491
2016-10-31 2016-09-30 13F Abbvie COM 00287Y109 948,084 -50,514 -5.06 59,796 -3.28 0.7179
2016-08-15 2016-06-30 13F/A-1 Abbvie COM 00287Y109 998,598 -39,207 -3.78 61,823 4.29 0.7366
2016-07-29 2016-06-30 13F Abbvie COM 00287Y109 998,598 61,823
2016-04-29 2016-03-31 13F Abbvie COM 00287Y109 1,037,805 188,100 22.14 59,279 17.76 0.7852
2016-01-29 2015-12-31 13F Abbvie COM 00287Y109 849,705 205,654 31.93 50,337 43.64 0.6824
2015-10-30 2015-09-30 13F Abbvie COM 00287Y109 644,051 92,976 16.87 35,043 -5.36 0.4688
2015-07-31 2015-06-30 13F Abbvie COM 00287Y109 551,075 376,964 216.51 37,027 263.29 0.4361
2015-04-30 2015-03-31 13F Abbvie COM 00287Y109 174,111 174,111 0.00 10,192 0.1198
2015-01-30 2014-12-31 13F Abbvie COM 00287Y109 0 -175,029 -100.00 0 -100.00
2014-10-30 2014-09-30 13F Abbvie COM 00287Y109 175,029 1,645 0.95 10,110 3.31 0.1122
2014-09-18 2014-06-30 13F/A-1 Abbvie COM 00287Y109 173,384 -62,536 -26.51 9,786 -19.30 0.0952
2014-07-30 2014-06-30 13F Abbvie COM 00287Y109 173,384 9,786
2014-04-30 2014-03-31 13F Abbvie COM 00287Y109 235,920 -29,598 -11.15 12,126 -13.52 0.1596
2014-01-30 2013-12-31 13F Abbvie COM 00287Y109 265,518 17,802 7.19 14,022 26.55 0.1885
2013-10-30 2013-09-30 13F Abbvie COM 00287Y109 247,716 2,295 0.94 11,080 9.21 0.1381
2013-07-30 2013-06-30 13F Abbvie COM 00287Y109 245,421 245,421 10,146 0.1374
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.